Navigating the complexities of rAAV vector manufacturing can be daunting for small and mid-sized biotech companies venturing into the exciting world of gene therapy. Ensuring consistent quality and optimizing production processes are paramount for success.

Dr. Eduard Ayuso speaks about how upstream and downstream process optimization using design of experiments, a platform approach and end-to-end capabilities can tackle manufacturing challenges and help to expedite drug development.